Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma

J Neuroimmunol. 2010 Jan 25;218(1-2):140-4. doi: 10.1016/j.jneuroim.2009.10.017. Epub 2009 Nov 14.

Abstract

The present study reports regression of pre-established experimental rat gliomas as a result of combining peripheral immunization using interferon gamma (IFNgamma) transduced autologous tumor cells with local intratumoral delivery of interleukin 7 (IL-7) by mesenchymal stromal cells. IL-7 alone significantly decreased the tumor area and this effect was enhanced with IFNgamma immunization. A higher density of intratumoral T-cells was observed in animals receiving combined therapies compared to rats receiving either cytokine alone suggesting that the therapeutic effect is dependent on a T-cell response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Glioma / therapy*
  • Immunohistochemistry
  • Immunotherapy / methods*
  • Interferon-gamma / administration & dosage*
  • Interleukin-7 / administration & dosage*
  • Lymphocytes, Tumor-Infiltrating / drug effects
  • Male
  • Mesoderm / transplantation
  • Neoplasms, Experimental / therapy
  • Rats
  • Rats, Inbred F344
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stromal Cells / transplantation*
  • T-Lymphocytes / immunology
  • Transduction, Genetic

Substances

  • Antineoplastic Agents
  • Interleukin-7
  • Interferon-gamma